Justus Duyster

One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor

Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall et al. · JAMA · 2012 · 969 citations

Medicine, Oncology, Surgery +12

NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβ

Florian R. Greten, Melek C. Arkan, Julia Bollrath et al. · Cell · 2007 · 611 citations · Full text

Life Sciences, Immunology, Molecular Biology +13

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Robert Zeiser, Andreas Burchert, Claudia Lengerke et al. · Leukemia · 2015 · 540 citations · Full text

Medicine, Clinical Sciences, Immunology +16

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study

Nikolas von Bubnoff, Folker Schneller, Christian Peschel et al. · The Lancet · 2002 · 462 citations

Medicine, Hematology, Oncology +15

Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease

Silvia Spoerl, Nimitha R. Mathew, Michael Bscheider et al. · Blood · 2014 · 394 citations

Life Sciences, Immunology, Pharmacotherapy +14